Recent advances of β-catenin small molecule inhibitors for cancer therapy: Current development and future perspectives
- 24 September 2022
- journal article
- review article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 243, 114789
Abstract
No abstract availableKeywords
This publication has 87 references indexed in Scilit:
- Integrated genomic characterization of endometrial carcinomaNature, 2013
- Novel mutations target distinct subgroups of medulloblastomaNature, 2012
- Dysregulation of Wnt/β-Catenin Signaling in Gastrointestinal CancersGastroenterology, 2012
- An intrinsically labile α-helix abutting the BCL9-binding site of β-catenin is required for its inhibition by carnosic acidNature Communications, 2012
- An RNAi-based chemical genetic screen identifies three small-molecule inhibitors of the Wnt/ wingless signaling pathwayProceedings of the National Academy of Sciences, 2011
- Small-molecule inhibition of Wnt signaling through activation of casein kinase 1αNature Chemical Biology, 2010
- Tankyrase inhibition stabilizes axin and antagonizes Wnt signallingNature, 2009
- Small molecule–mediated disruption of Wnt-dependent signaling in tissue regeneration and cancerNature Chemical Biology, 2009
- Targeting the β-catenin/TCF transcriptional complex in the treatment of multiple myelomaProceedings of the National Academy of Sciences, 2007
- THE WNT SIGNALING PATHWAY IN DEVELOPMENT AND DISEASEAnnual Review of Cell and Developmental Biology, 2004